Bellerophon Therapeutics, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Bellerophon Therapeutics, Inc. Website Screenshot

http://www.bellerophon.com

Bellerophon Therapeutics, Inc. Company Intro

Bellerophon Therapeutics is a clinical-stage biotherapeutics company. We are focused on developing innovative therapies in the treatment of cardiopulmonary diseases. Our mission is to develop well-studied molecules deployed through innovative delivery systems to treat diseases with significant unmet clinical need. More … Continued

Industry

Healthcare

Bellerophon Therapeutics, Inc. Headquaters

184 Liberty Corner Road
Warren,07059
United States


Bellerophon Therapeutics, Inc. Share price

27 Oct 2020 01:14 GMT

$9.03

0.0 (0.0 %)


Bellerophon Therapeutics, Inc. Market cap

$83.96 M


WMC RANKING

2020

Bellerophon Therapeutics, Inc. # 402

Biotechnology



Latest Bellerophon Therapeutics, Inc. News

News 26 Oct 2020

Nitric Oxide Therapy System Consumption Market Size 2020 By Product Types, End-Users, Regional Outlook, Growth, Trends And Forecast To 2027 | Market Research Intellect

Bellerophon Therapeutics; BOC Healthcare; Dan Hammer Health LTD; EKU ... International Biomedical; SLE; Mallinckrodt Pharmaceuticals; Praxair; Inc.

News 26 Oct 2020

Interstitial Pneumonia Market Brief Analysis And Application, Growth By 2026 |Bellerophon Therapeutics, Inc, Bayer

Boehringer Ingelheim, Bellerophon Therapeutics, Inc, Bayer, Fujirebio (Miraca), Philips, Merck, … Leading key players of the global Interstitial Pneumonia market ...

News 26 Oct 2020

Interstitial Lung Disease (ILD) Market Report, History And Forecast 2020-2026|Bellerophon Therapeutics, Inc, Bayer

Boehringer Ingelheim, Bellerophon Therapeutics, Inc, Bayer, Fujirebio (Miraca), Philips, Merck, Siemens Healthineers, … Leading key players of the global ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Bellerophon Therapeutics, Inc. 0 0 0 0 0 0 0
Alexion Pharmaceuticals, Inc. 100 13.31 100 0 0 0 100
Vertex Pharmaceuticals Incorporated 97.58 100 4.32 0 0 0 92.06
3SBio Inc. 96.05 0 0 0 0 0 0
Incyte Corporation 40.27 14.26 7.19 0 0 0 18.93

Bellerophon Therapeutics, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Bellerophon Therapeutics, Inc. $0 $18,775 $-17,157 $83.96M 402
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.467B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $53.956B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.394B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.779B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Bellerophon Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors



Bellerophon Therapeutics, Inc. Post vs Top 4 Industry Competitors


Book a demo

Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.

* required fields

You'll learn how to:

  • 1. Automatically monitor your entire digital landscape including competitors
  • 2. View all new industry activity in real time
  • 3. Monitor your position in your industry
  • 4. Enrich your reports and strategy
  • 5. Empower your teams with knowledge

Our platform is loved & trusted by avariety
of world-leading brands

  • unilever
  • wavesight
  • acca
  • abeerdeen
  • UK2
  • umbo
  • rb
Industries